ProCE Banner Activity

患者对 HIV 治疗和预防的需求:治疗方法

在这一视频圆桌会议中,从患者倡权人和专家处了解到全球范围内阻碍 HIV 治疗的主要障碍,以及医疗保健专业人员可以做些什么来克服它们。

Released: December 21, 2022

Expiration: February 03, 2023

No longer available for credit.



Iskandar Azwa

Iskandar Azwa, MBChB

Associate Professor
Infectious Diseases, Faculty of Medicine
University of Malaya
Kuala Lumpur, Malaysia

Deondre Moore

Deondre Moore,

Angelina Namiba

Angelina Namiba,


Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Learning Objectives


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Iskandar Azwa, MBChB

Associate Professor
Infectious Diseases, Faculty of Medicine
University of Malaya
Kuala Lumpur, Malaysia

Iskandar Azwa,内外全科医学士,没有要披露的相关财务关系。

Deondre Moore,

Deondre Moore 没有要披露的相关财务关系。

Angelina Namiba,

Angelina Namiba 没有要披露的相关财务关系。

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 21, 2022, through February 03, 2023:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50.00% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.